Latest treatment of multiple sclerosis Stories
TOORAK, Australia, Sept.
~Crew of Sailors with MS including Bostonian Demonstrate Ability to Overcome Personal Challenges BOSTON, Sept.
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
NESS ZIONA, Israel, May 27, 2014 /PRNewswire/ -- Mapi Pharma Ltd.
MISSISSAUGA, ON, May 27, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in Ontario through the Ontario Public Drugs
- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated
Crowdfunding Gets FDA-Approved Stem Cell Trial Off To Fast Start New York, NY (PRWEB) April 15, 2014 The Tisch MS Research Center of New York (Tisch
- A transitional zone between two communities containing the characteristic species of each.